The correlation between the expression of BCL-2 in T cells and various clinical characteristics of patients with CLL is summarized in Table 4, which shows a positive correlation between BCL-2 expression in T cells and β2-MG (χ2 = 3.916, P < 0.05). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.